The analysis of the Hormones in Dosage Except Contraceptives and Antibiotics Market size value per capita in Slovakia from 2013 to 2023 reveals a declining trend. The market value per capita decreased from $19.44 in 2013 to $6.51 in 2023. Year-on-year, the value dropped by approximately 12% between 2022 and 2023. Over the last two years, there was a sharper decline, and calculating the CAGR for the last five years indicates an average annual decline of about 12%.
Looking ahead, key trends to monitor include potential stabilization in the market as the decline decelerates, and watch for regulatory changes or innovations that may influence usage patterns of hormone therapies. Additionally, demographic shifts and healthcare policy adjustments in Slovakia could impact growth or further contraction in this segment.
